Fastest, Cleanest, Highest‑ROI Path for Electrome and BIEL.
Model where Electrome acquires 1 billion BIEL shares to leverage:
BIEL’s public‑market upside
Electrome’s balance‑sheet optimization
Treasury‑style profit harvesting
Debt elimination
Accelerated manufacturing scale
A unified commercial ecosystem
Electrome Benefits / ROI From Buying 1B Shares of BIEL
Electrome’s acquisition of 1B BIEL shares becomes strategically compelling when you combine:
BIEL’s near‑instant path to profitability via interest elimination
Electrome’s need for low‑cost capital, public‑market leverage, and treasury growth
The fact that Electrome is already a major commercial partner with active purchase orders
BIEL’s $41M tax‑loss carryforward, which shields future profits from taxes
This creates a scenario where Electrome can:
Retire BIEL’s interest expense
Trigger immediate profitability
Capture extreme PPS upside
Strengthen its own balance sheet
Secure manufacturing priority
Control a strategic medical‑device asset
Scenario: Electrome Acquires 1B Shares of BIEL
1. Strategic Rationale for Electrome
Electrome is a private company. Private companies often seek:
Treasury assets that can appreciate rapidly
Low‑cost capital pathways
Public‑market leverage without going public
Control over critical supply chain partners
Buying 1B shares of BIEL accomplishes all of these.
A. Treasury Growth via PPS Explosion
If BIEL hits $250K net profit, PPS = .01 (P/E = 1000) .
Electrome’s 1B shares would be worth:
$10M at .01 PPS
$20M at .02 PPS
$40M at .04 PPS (aligned with $1M profit scenario)
This becomes a treasury asset Electrome can use for:
Borrowing collateral
Balance‑sheet strengthening
Strategic liquidity
Future acquisitions
Electrome essentially gains a public‑market engine without becoming public.
B. Eliminating BIEL’s Interest Expense
Electrome’s investment can be structured to retire BIEL’s $613K interest expense, which instantly flips net income from –$532K to +$81K .
This is the fastest path to profitability.
Electrome benefits because:
A profitable BIEL increases Electrome’s treasury value
Profitability accelerates PPS appreciation
BIEL becomes a stronger manufacturing partner
Electrome gains influence over financial strategy
C. Securing Manufacturing Priority
Electrome already issued a purchase order and manufacturing is underway .
By owning 1B shares, Electrome ensures:
Guaranteed production priority
Faster scale‑up
Lower unit costs
Preferential inventory allocation
Strategic control over supply chain risk
D. Funding Without Loans
Instead of borrowing:
Electrome invests in BIEL
BIEL uses funds to retire debt
Electrome gains a rapidly appreciating asset
Both companies avoid high‑interest financing
This is cheaper, faster, and safer than traditional loans.
Deal Structure: How Electrome Buys 1B Shares
1. Direct Equity Purchase
Electrome buys 1B newly issued shares at a negotiated price (e.g., .0003–.0005) or open market
Proceeds are used to:
Retire high‑interest debt
Expand manufacturing
Fund marketing
Build inventory
2. Debt Retirement Mechanism
Electrome’s capital is used to:
Pay off lenders
Eliminate interest expense
Trigger immediate profitability
This is the fastest path to PPS = .01.
3. Strategic Partnership Agreement
Electrome receives:
Board representation
Manufacturing priority
Exclusive rights for certain markets
Treasury‑grade equity position
BIEL receives:
Debt elimination
Capital infusion
Guaranteed commercial volume
Accelerated revenue growth
Financial Impact of the Deal
1. Immediate Net Profit
Interest expense eliminated → +$613K swing .
Net income becomes +$81K instantly.
2. PPS Reaction
Market sees:
Debt eliminated
Electrome stake
Guaranteed revenue
Manufacturing scale
Profitability
This triggers PPS movement toward .01.
Electrome’s 1B shares become a multi‑million‑dollar treasury asset.
3. Revenue Acceleration
Electrome’s commercial launch adds $300K–$500K revenue, producing $255K–$425K gross profit due to BIEL’s 85% margin .
Combined with interest elimination, BIEL easily surpasses $250K net profit.
Why This Scenario Is Realistic
Electrome is already a major commercial partner
Electrome’s financing can eliminate interest expense
Debt conversion is common in microcaps
BIEL is already operating profitably (+$81K) before interest
Interest elimination is the fastest path to PPS = .01
Electrome buying 1B shares is simply the logical extension of these mechanisms.
Final Business Case
Electrome acquires 1B BIEL shares because it allows them to:
Eliminate BIEL’s interest expense
Trigger immediate profitability
Drive PPS to copper (.01)
Add $10M–$40M to their treasury
Secure manufacturing priority
Expand commercial footprint
Access public‑market leverage
Avoid traditional loans
Strengthen both companies simultaneously
This is the fastest, cleanest, highest‑ROI path for both Electrome and BIEL.
Model where Electrome acquires 1 billion BIEL shares to leverage:
BIEL’s public‑market upside
Electrome’s balance‑sheet optimization
Treasury‑style profit harvesting
Debt elimination
Accelerated manufacturing scale
A unified commercial ecosystem
Electrome Benefits / ROI From Buying 1B Shares of BIEL
Electrome’s acquisition of 1B BIEL shares becomes strategically compelling when you combine:
BIEL’s near‑instant path to profitability via interest elimination
Electrome’s need for low‑cost capital, public‑market leverage, and treasury growth
The fact that Electrome is already a major commercial partner with active purchase orders
BIEL’s $41M tax‑loss carryforward, which shields future profits from taxes
This creates a scenario where Electrome can:
Retire BIEL’s interest expense
Trigger immediate profitability
Capture extreme PPS upside
Strengthen its own balance sheet
Secure manufacturing priority
Control a strategic medical‑device asset
Scenario: Electrome Acquires 1B Shares of BIEL
1. Strategic Rationale for Electrome
Electrome is a private company. Private companies often seek:
Treasury assets that can appreciate rapidly
Low‑cost capital pathways
Public‑market leverage without going public
Control over critical supply chain partners
Buying 1B shares of BIEL accomplishes all of these.
A. Treasury Growth via PPS Explosion
If BIEL hits $250K net profit, PPS = .01 (P/E = 1000) .
Electrome’s 1B shares would be worth:
$10M at .01 PPS
$20M at .02 PPS
$40M at .04 PPS (aligned with $1M profit scenario)
This becomes a treasury asset Electrome can use for:
Borrowing collateral
Balance‑sheet strengthening
Strategic liquidity
Future acquisitions
Electrome essentially gains a public‑market engine without becoming public.
B. Eliminating BIEL’s Interest Expense
Electrome’s investment can be structured to retire BIEL’s $613K interest expense, which instantly flips net income from –$532K to +$81K .
This is the fastest path to profitability.
Electrome benefits because:
A profitable BIEL increases Electrome’s treasury value
Profitability accelerates PPS appreciation
BIEL becomes a stronger manufacturing partner
Electrome gains influence over financial strategy
C. Securing Manufacturing Priority
Electrome already issued a purchase order and manufacturing is underway .
By owning 1B shares, Electrome ensures:
Guaranteed production priority
Faster scale‑up
Lower unit costs
Preferential inventory allocation
Strategic control over supply chain risk
D. Funding Without Loans
Instead of borrowing:
Electrome invests in BIEL
BIEL uses funds to retire debt
Electrome gains a rapidly appreciating asset
Both companies avoid high‑interest financing
This is cheaper, faster, and safer than traditional loans.
Deal Structure: How Electrome Buys 1B Shares
1. Direct Equity Purchase
Electrome buys 1B newly issued shares at a negotiated price (e.g., .0003–.0005) or open market
Proceeds are used to:
Retire high‑interest debt
Expand manufacturing
Fund marketing
Build inventory
2. Debt Retirement Mechanism
Electrome’s capital is used to:
Pay off lenders
Eliminate interest expense
Trigger immediate profitability
This is the fastest path to PPS = .01.
3. Strategic Partnership Agreement
Electrome receives:
Board representation
Manufacturing priority
Exclusive rights for certain markets
Treasury‑grade equity position
BIEL receives:
Debt elimination
Capital infusion
Guaranteed commercial volume
Accelerated revenue growth
Financial Impact of the Deal
1. Immediate Net Profit
Interest expense eliminated → +$613K swing .
Net income becomes +$81K instantly.
2. PPS Reaction
Market sees:
Debt eliminated
Electrome stake
Guaranteed revenue
Manufacturing scale
Profitability
This triggers PPS movement toward .01.
Electrome’s 1B shares become a multi‑million‑dollar treasury asset.
3. Revenue Acceleration
Electrome’s commercial launch adds $300K–$500K revenue, producing $255K–$425K gross profit due to BIEL’s 85% margin .
Combined with interest elimination, BIEL easily surpasses $250K net profit.
Why This Scenario Is Realistic
Electrome is already a major commercial partner
Electrome’s financing can eliminate interest expense
Debt conversion is common in microcaps
BIEL is already operating profitably (+$81K) before interest
Interest elimination is the fastest path to PPS = .01
Electrome buying 1B shares is simply the logical extension of these mechanisms.
Final Business Case
Electrome acquires 1B BIEL shares because it allows them to:
Eliminate BIEL’s interest expense
Trigger immediate profitability
Drive PPS to copper (.01)
Add $10M–$40M to their treasury
Secure manufacturing priority
Expand commercial footprint
Access public‑market leverage
Avoid traditional loans
Strengthen both companies simultaneously
This is the fastest, cleanest, highest‑ROI path for both Electrome and BIEL.
1
